Primers Corresponding to A = C Plasmid in Yersinia ruckeri and Salmonella Newport Primer name Sequence 50 - 30 Yersinia ruckeri Salmonella Newport CmyFW2 HypRV1 HypFW2 TraAFW2 TraCRV1 CGGCCTGGCGCATTCTTGAAAAGC CGAAATCATGTTGGCTCATGATCCC CTCTGGTTGGGGTCGTGACT GGCTGTTGTGCAACTCAGCAATG GTGCTGCGGGATCAACGTTTC Not present 64820 -- 64840 67961 -- 67981 62248 -- 62270 68899 -- 68919 73481 -- 73505 , 68825 -- 68848 77471 -- 77492 , 68825 -- 68848 80512 -- 80632 , 61697 -- 61717 58828 -- 58850 81540 -- 81570 EMBL GenBank accession numbers used for comparisons were CP000602 ( Y. ruckeri ) and CP000604 ( Salmonella Newport ) .

The Number of Salmonella Isolates ( n 1/4 205 ) Categorized by Serovar , Resistance Proﬁle , and Replicon Genotype Newport Reading Kinshasa Agona Typhimurium ( n 1/4 126 ) ( n 1/4 34 ) ( n 1/4 20 ) ( n 1/4 6 ) ( n 1/4 9 ) Infantis ( n 1/4 2 ) Give ( n 1/4 8 ) Resistance No .

of isolates , replicon ( s ) Presence of blaCMY þ þ þ þ þ þ þ þ 3 A = C AkAmApFT ( Ax ) CGKSSuTe AmApFT ( Ax ) CGKSSuTe AmApFT ( Ax ) CKSSuTe AmApFTAxCKSSuTe AmApFT ( Ax ) CGSSuTe AmApFT ( Ax ) CSSuTe AmApFTAxCSSuTe AmApFT ( Ax ) CSSuTe ApCSSuTe CKSSuTe CKSSuTe CSSuTe CSSuTe KSTe Pansusceptible Pansusceptible Pansusceptible Pansusceptible 3 A = C , B =O 17 A = C , B = O 1 A = C , B =O 23 A = C 27 A = C 30 A = C 5 A = C , HI1 1 A = C 2 A = C , B = O 3 A = C 16 A = C 13 A = C 2 A = C , N 0 3 A = C 5 A = C , HI2 4 A = C 2 A = C , I1 8 FIA , FIB , I1 24 None 1 I1 1 A = C 1 FIC 1 None Resistance phenotype is deﬁned as resistance to the following antimicrobial agents : Ak , amikacin ; Am , amoxicillin = clavulanic acid ; Ap , ampicillin ; F , cefoxitin ; T , ceftiofur ; Ax , ceftriaxone ( Ax ) , intermediate susceptibility to ceftriaxone ( 16 -- 32 mg = L ) ; C , chloramphenicol ; Cp , ciproﬂoxacin ; G , gentamicin ; K , kanamycin ; N , nalidixic acid ; R , rifampicin ; S , streptomycin ; Su , sulﬁzoxazole ; Te , tetracycline ; Sxt , trimethoprim = sulfamethoxazole .

Transconjugant Phenotypes and Genotypes Obtained from Salmonella Donors with the JM109 Recipient Donor Donor resistance Transconjugant resistance Transconjugantreplicon replicon type phenotype Donor phenotype type Transconjugant blaCMY blaCMY þ þ þ þ þ þ Salmonella Newport , n 1/4 1 Salmonella Infantis , n 1/4 2 Salmonella Kinshasha , n 1/4 16 Salmonella Kinshasha , n 1/4 3 Salmonella Newport , n 1/4 2 Salmonella Newport , n 1/4 1 ( SN11 ) Salmonella Newport , n 1/4 1 ( SN14 ) Salmonella Newport , n 1/4 2 AmApFT ( Ax ) CGKSSuTe AmApFT ( Ax ) CGKSSuTe AmApFT ( Ax ) CGKSSuTe AkAmApFT ( Ax ) CGKSSuTe CSSuTe AmApFTAxCSSuTe A = C , B =O A = C , B =O A = C , B =O A = C , B =O A = C , I1 A = C , N AmApFT ( Ax ) CGKSSuTeNR AmApFT ( Ax ) CGKSSuTeNR AmApFT ( Ax ) CGKSSuTeNR AkAmApFT ( Ax ) CGKSSuTeNR CSSuTeNR AmCSSuTeNR A = C , B =O A = C , B =O A = C , B =O A = C , B =O A = C , I1 N þ þ þ þ þ AmApFTAxCSSuTe A = C , N AmApFTAxCSSuTeNR A = C , N þ þ AmApFTAxCKSSuTe A = C AmApFTAxCKSSuTeNR ; CKSSuTeNR AmApFT ( Ax ) CSSuTeNR ; CSSuTeNR CKSSuTeNR CSSuTeNR KSTeNR A = C , untypable A = C , untypable A = C A = C FIA , FIB , I1 ; FIA , FIB A = C , HI2 HI1 Salmonella Newport , n 1/4 2 þ þ AmApFT ( Ax ) CSSuTe A = C Salmonella Newport , n 1/4 3 Salmonella Newport , n 1/4 4 Salmonella Give , n 1/4 8 CKSSuTe CSSuTe KSTe A = C A = C FIA , FIB , I1 Salmonella Newport , n 1/4 5 Salmonella Agona , n 1/4 4 CKSSuTe A = C , HI2 A = C , HI1 CKSSuTeNR GKSTeNR AmApFT ( Ax ) CGKSSuTe Resistance phenotype is deﬁned as resistance to the following antimicrobial agents : Ak , amikacin ; Am , amoxicillin = clavulanic acid ; Ap , ampicillin ; F , cefoxitin ; T , ceftiofur ; Ax , ceftriaxone ( Ax ) , intermediate susceptibility to ceftriaxone ( 16 -- 32 mg = L ) ; C , chloramphenicol ; Cp , ciproﬂoxacin ; G , gentamicin ; K , kanamycin ; N , nalidixic acid ; R , rifampicin ; S , streptomycin ; Su , sulﬁzoxazole ; Te , tetracycline ; Sxt , trimethoprim = sulfamethoxazole Table 4 .

E. coli CVM1572 E. coli DH5a Escherichia coli JM109 Salmonella Newport SN50 Donor strain Inc type Conjugation frequency 10 1.2 02 NTD 10 2.8 02 10 3.6 02 10 1.2 03 10 8.4 04 10 8.1 02 10 7.4 01 NTD 10 3.7 01 10 4.4 02 10 4.6 02 10 8.1 02 10 4.1 02 10 1.9 10 07 07 NTD 10 6.29 10 03 03 10 7.03 10 04 05 10 4.1 10 05 05 10 1.5 10 07 07 10 2.8 10 07 07 10 2.4 03 NTD 10 2.3 03 10 2.4 03 10 4.9 04 10 8.5 04 10 1.3 03 10 02 10 02 03 I1 , FIB , FIC , P A = C A = C , N A = C , N A = C , I1 A = C , I1 A = C CVM1548 SN4 SN11 SN14 SN39 SN40 SN82 6.37 2.01 5.19 6.70 10 10 02 10 02 03 03 5.65 1.40 3.60 6.57 7.12 1.05 4.42 6.94 6.12 5.37 6.46 5.74 3.12 2.93 2.02 4.53 7.30 5.23 8.14 9.78 10 10 10 10 10 10 03 10 03 10 03 10 03 10 02 10 02 10 02 10 02 04 05 03 Discussion Food animal producers are interested in farm management practices that will prevent infection and future dissemination of MDR pathogens .

